Načítá se...
Clinical and immunological correlates of long term survival in glioblastoma
Glioblastoma (GBM) is the most common and most aggressive type of primary brain tumour in adults. It represents 54% of all gliomas and 16% of all brain tumours (Ostrom et al. 2016). Despite surgery and treatment with radiotherapy plus an oral alkylating agent, temozolomide (TMZ), tumours invariably...
Uloženo v:
| Vydáno v: | Contemp Oncol (Pozn) |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Termedia Publishing House
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5885076/ https://ncbi.nlm.nih.gov/pubmed/29628799 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/wo.2018.73893 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|